George D. Yancopoulos

2020

In 2020, George D. Yancopoulos earned a total compensation of $134.4M as President and Chief Scientific Officer at Regeneron Pharmaceuticals, a 550% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$3,004,391
Salary$1,258,096
Stock Awards$130,000,032
Other$120,800
Total$134,383,319

Yancopoulos received $130M in stock awards, accounting for 97% of the total pay in 2020.

Yancopoulos also received $3M in non-equity incentive plan, $1.3M in salary and $120.8K in other compensation.

Rankings

In 2020, George D. Yancopoulos' compensation ranked 13th out of 8,688 executives tracked by ExecPay. In other words, Yancopoulos earned more than 99.9% of executives.

ClassificationRankingPercentile
All
13
out of 8,688
100th
Division
Manufacturing
2
out of 3,671
100th
Major group
Chemicals And Allied Products
2
out of 1,317
100th
Industry group
Drugs
2
out of 1,116
100th
Industry
Pharmaceutical Preparations
2
out of 838
100th
Source: SEC filing on April 23, 2021.

Yancopoulos' colleagues

We found four more compensation records of executives who worked with George D. Yancopoulos at Regeneron Pharmaceuticals in 2020.

2020

Leonard Schleifer

Regeneron Pharmaceuticals

Chief Executive Officer

2020

Andrew Murphy

Regeneron Pharmaceuticals

Executive Vice President, Research

2020

Daniel Van Plew

Regeneron Pharmaceuticals

Executive Vice President and General Manager, Industrial Operations and Product Supply

2020

Robert Landry

Regeneron Pharmaceuticals

Chief Financial Officer

News

You may also like